R50G (p.Arg50Gly) variant of APOE (Apolipoprotein E)

R50G (p.Arg50Gly) in APOE (Apolipoprotein E) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.64 / 1. The record also includes population frequency data and structural context.

R50G (p.Arg50Gly) variant details